Abstract
Medical research must translate into improved treatments for patients with advancement in proteomics
technology. This will allow us to measure thousands of molecules at a given point in time. These
molecules in form of biomarkers give clues about underlying biological processes in health and disease
as they are used to monitoring a disease or predict the outcome of a treatment The resulting insights will
provide novel drug targets and protein-based markers contributing towards a futuristic basis for
personalized medicine.
The emerging field of proteomics and the spectacular progress of proteomic technologies is a mainstay of
biological research and clinical translation, for more effective analysis of human disease and for the
identification and validation of biomarkers. It is only recently that post-genomic research, with evolving
new fields in science, provides insights that will benefit both basic medical research and clinical
applications by permitting deeper understanding of the genotype-phenotype relationship, mechanistic and
functional insights capturing the details of physiological states.
